Product Categories
| Country: | China |
|---|---|
| Tel: | 021-18017925 |
| Mobile: | +8618916360931 |
| E-mail: | 2596183085@qq.com |
| QQ: | 2596183085 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| Fluoxetine hydrochloride | C17H19ClF3NO | 56296-78-7 | Details |
| Puerarin-4'-O-β-D-glucopyranoside | C27H30O14 | 117047-08-2 | Details |
| (S)-Lisofylline | C13H20N4O3 | 100324-80-9 | Details |
| (Rac)-ABT-202 dihydrochloride | C9H14ClN3 | 1258641-38-1 | Details |
| EML4-ALK kinase inhibitor 1 | C31H48N8O3 | 1373409-08-5 | Details |
| UC-1728 | C21H21F3N2O5 | 948304-40-3 | Details |
| ADRA1D receptor antagonist 1 HCl | C15H14Cl2N4O | 1191908-14-1 | Details |
| Leukotriene D4 | C25H40N2O6S | 73836-78-9 | Details |
| Epimagnolin A | C23H28O7 | 41689-51-4 | Details |
| O6-Methyldeoxy guanosine | C11H15N5O4 | 964-21-6 | Details |
| STD1T | C19H19N3O4S2 | 893075-58-6 | Details |
| eIF4A3-IN-1 | C29H23BrClN5O2 | 2095486-67-0 | Details |
| Emzadirib | C27H40N4O6S2 | 2301085-04-9 | Details |
| LASV inhibitor 3.3 | C30H37N3O2 | 554438-52-7 | Details |
| BRCA1-IN-2 | C26H33N4O7P | 1622262-55-8 | Details |
| Tetrazine-Ph-NHCO-C3-NHS ester | C18H18N6O5 | 1244040-64-9 | Details |
| KRAS G12D inhibitor 14 | C20H19F3N4OS | 2765254-39-3 | Details |
| Radioprotectin-1 | C23H19ClN2O6S | 1622006-09-0 | Details |
| Tavilermide | C24H32N6O11 | 263251-78-1 | Details |
| Usmarapride free base | C21H29N5O2 | 1428862-32-1 | Details |
| TP003 | C23H16F3N3O | 628690-75-5 | Details |
| Tazomeline | C14H23N3S2 | 131987-54-7 | Details |
| Pipoxizine | C24H31NO3 | 55837-21-3 | Details |
| Paeonolide | C20H28O12 | 72520-92-4 | Details |
| Irtemazole | C18H16N4 | 129369-64-8 | Details |
| Fezolamine | C20H23N3 | 80410-36-2 | Details |
| Upacicalcet | C11H14ClN3O6S | 1333218-50-0 | Details |
| Sergliflozin A | C20H24O7 | 360775-96-8 | Details |
| Cholestyramine | C27H47N | 11041-12-6 | Details |
| Clomipramine hydrochloride | C19H24Cl2N2 | 17321-77-6 | Details |
| Taurohyodeoxycholic acid sodium salt | C26H46NNaO6S | 38411-85-7 | Details |
| Endo-1,4-β-xylanase | 9025-57-4 | Details |
| AWL-II-38.3 | C23H18F3N5O3 | 1135205-94-5 | Details |
| Periplogenin 3-[O-β-glucopyranosyl-(1→4)-β-sarmentopyranoside] | C36H56O13 | 1253421-94-1 | Details |
| BCL6-IN-3 | C24H31ClF2N6O2 | 2253878-44-1 | Details |
| Beclomethasone 17-propionate | C25H33ClO6 | 5534-18-9 | Details |
| CMP-5 2HCl | C21H22ClN3 | 2309409-79-6 | Details |
| Tubulin polymerization-IN-47 | C22H21N3O3 | 2834087-62-4 | Details |
| Busulfan-d8 | C6H6D8O6S2 | 116653-28-2 | Details |
| Tectol | C30H26O4 | 24449-39-6 | Details |
| AMPA receptor modulator-1 | C16H11ClF3NO2 | 2036074-41-4 | Details |
| AZD 3147 | C24H31N5O4S2 | 1101810-02-9 | Details |
| TH1338 | C22H21N3O4 | 1258494-60-8 | Details |
| Ebopiprant | C30H34FN3O5S2 | 2005486-31-5 | Details |
| Sylvestroside I | C33H48O19 | 71431-22-6 | Details |
| Giredestrant tartrate | C31H37F5N4O7 | 2407529-33-1 | Details |
| Pavinetant | C26H25N3O3S | 941690-55-7 | Details |
| Imidazenil | C18H12BrFN4O | 151271-08-8 | Details |
| SR-318 | C27H33N5O2 | 2413286-32-3 | Details |
| KB-74935 | C19H18ClF4N3O3S | 946398-78-3 | Details |
| 1-beta-D-Arabinofuranosylthymine | C10H14N2O6 | 605-23-2 | Details |
| Brentuximab vedotin | 914088-09-8 | Details |
| Pimethixene maleate | C23H23NO4S | 13187-06-9 | Details |
| IRG1-IN-1 | C18H15FO4 | 2407652-42-8 | Details |
| Methyl carnosate | C21H30O4 | 82684-06-8 | Details |
| TAS-114 | C21H29N3O6S | 1198221-21-4 | Details |
| TPC2-A1-N | C17H9Cl2F3N2O2 | 136186-07-7 | Details |
| (-)-Apomorphine hydrochloride hydrate | C17H20ClNO3 | 58117-94-5 | Details |
| ArnicolideC | C19H26O5 | 34532-67-7 | Details |
| Nortrachelogenin-8'-O-beta-glucoside | C26H32O12 | 858127-38-5 | Details |
| Sirt2-IN-1 | C28H27N7O2S2 | 1862238-00-3 | Details |
| Emodin 6-O-β-D-glucoside | C21H20O10 | 34298-85-6 | Details |
| AZ13705339 | C33H36FN7O3S | 2016806-57-6 | Details |
| PAT-505 | C23H18ClF2N3O2S | 1782070-22-7 | Details |
| β-Phellandrene | C10H16 | 555-10-2 | Details |
| Iriflophenone 3-C-glucoside | C19H20O10 | 104669-02-5 | Details |
| SPOP-IN-6b | C28H32N6O3 | 2136270-20-5 | Details |
| Glibornuride | C18H26N2O4S | 26944-48-9 | Details |
| Polyphyllin H | C44H70O17 | 81917-50-2 | Details |
| 2-Methyl-5-HT | C11H14N2O | 78263-90-8 | Details |
| Ganfeborole HCl | C10H14BCl2NO4 | 2131798-13-3 | Details |
| Ganoderic acid B | C30H44O7 | 81907-61-1 | Details |
| Normetanephrine hydrochloride | C9H13NO3.ClH | 1011-74-1 | Details |
| Dipsanoside A | C66H90O37 | 889678-62-0 | Details |
| Zastaprazan | C22H26N4O | 2133852-18-1 | Details |
| TR antagonist 1 | C25H23Br2NO4 | 500794-88-7 | Details |
| (R)-STU104 | C18H18O4 | 2767124-77-4 | Details |
| Xanthoangelol | C25H28O4 | 62949-76-2 | Details |
| Aramchol | C44H79NO5 | 246529-22-6 | Details |
| Ibrexafungerp | C44H67N5O4 | 1207753-03-4 | Details |
| Pristinamycin IA | C45H54N8O10 | 3131-03-1 | Details |
| (R)-BPO-27 | C26H18BrN3O6 | 1415390-47-4 | Details |
| 3-O-p-Coumaroylquinic acid | C16H18O8 | 5746-55-4 | Details |
| Monocrotaline N-Oxide | C16H23NO7 | 35337-98-5 | Details |
| Nemonoxacin | C20H25N3O4 | 378746-64-6 | Details |
| MRT68921 dihydrochloride | C25H35ClN6O | 2080306-21-2 | Details |
| ATPase-IN-3 | C10H6N2O3S2 | 1134203-12-5 | Details |
| Sufotidine | C20H31N5O3S | 80343-63-1 | Details |
| Adaphostin | C24H27NO4 | 241127-58-2 | Details |
| IOX2 | C19H16N2O5 | 931398-72-0 | Details |
| LY2794193 | C16H18N2O6 | 2173037-97-1 | Details |
| (R)-Simurosertib | C17H19N5OS | 1330782-69-8 | Details |
| HET0016 | C12H18N2O | 339068-25-6 | Details |
| 4-Chloro-L-phenylalanine | C9H10ClNO2 | 14173-39-8 | Details |
| Tangshenoside I | C29H42O18 | 117278-74-7 | Details |
| (E/Z)-E64FC26 | C19H23F3O2 | 2285446-67-3 | Details |
| Cephaeline | C28H38N2O4 | 483-17-0 | Details |
| Otenabant hydrochloride | C25H26Cl3N7O | 686347-12-6 | Details |
| Aviptadil Acetate | 1444827-29-5 | Details |
| Ensituximab | 1092658-06-4 | Details |
| Product Total： Product Page： | ||||
| 146 147 148 149 150 151 152 153 154 155 156 157 158 159 160 161 162 163 164 165 166 167 168 169 170 171 172 173 | ||||